Concepedia

Publication | Open Access

Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS

61

Citations

17

References

2021

Year

Abstract

In PPMS, effector B-cell depletion changed T-cell response toward a low inflammatory profile, resulting in decreased sNfL levels.

References

YearCitations

Page 1